Neobe Therapeutics Ltd (13146056) is a private limited with share capital incorporated on 20/01/2021 (5 years old) and registered in cambridge, CB12LA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
At neobe therapeutics we are engineering tumour-colonizing bacteria that will disrupt tumour micro environment barriers and enable immunotherapies in patients with immune-excluded tumours. only around 20% of patients with solid tumors are estimated to currently benefit from immunotherapies. multiple...
Termination Director Company With Name Termination Date
Category:Officers
Date:28-09-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:28-09-2026
Mortgage Satisfy Charge Full
Category:Mortgage
Date:06-07-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:14-05-2026
Mortgage Create With Deed With Charge Number Charge Creation Date
Category:Mortgage
Date:30-04-2026
Confirmation Statement With Updates
Category:Confirmation Statement
Date:03-02-2026
Change Person Director Company With Change Date
Category:Officers
Date:30-01-2026
Appoint Corporate Director Company With Name Date
Category:Officers
Date:19-12-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:19-12-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:29-08-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:21-01-2025
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:22-10-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:22-10-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-01-2024
Memorandum Articles
Category:Incorporation
Date:26-01-2024
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:26-01-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-01-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-01-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:26-01-2024
Change Person Director Company With Change Date
Category:Officers
Date:26-01-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:22-01-2024
Capital Allotment Shares
Category:Capital
Date:22-01-2024
Capital Allotment Shares
Category:Capital
Date:20-01-2024
Capital Allotment Shares
Category:Capital
Date:20-01-2024
Resolution
Category:Resolution
Date:15-01-2024
Resolution
Category:Resolution
Date:15-01-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:12-01-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:23-11-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:31-05-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-02-2023
Capital Allotment Shares
Category:Capital
Date:16-02-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-06-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-06-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-06-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-06-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:06-06-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:06-06-2022
Change Person Director Company With Change Date
Category:Officers
Date:06-06-2022
Change Person Director Company With Change Date
Category:Officers
Date:06-06-2022
Change Person Director Company With Change Date
Category:Officers
Date:06-06-2022
Change Person Director Company With Change Date
Category:Officers
Date:06-06-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:06-06-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:05-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-01-2022
Capital Allotment Shares
Category:Capital
Date:21-05-2021
Memorandum Articles
Category:Incorporation
Date:19-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:13-05-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:12-05-2021
Change Person Director Company With Change Date
Category:Officers
Date:26-01-2021
Change Person Director Company With Change Date
Category:Officers
Date:26-01-2021
Change Person Director Company With Change Date
Category:Officers
Date:26-01-2021
Incorporation Company
Category:Incorporation
Date:20-01-2021
Innovate Grants
4
This company received a grant of £262808.0 for Engineering A New Versican Remodeling Recombinant Bacterial Product To Enable Immunotherapy Success In Triple Negative Breast Cancer. The project started on 01/05/2022 and ended on 30/04/2024.
This company received a grant of £699917.0 for Pre-Clinical Development Of A Live Biotherapeutic Product Engineered To Remodel Hyaluronic Acid In Solid Tumours To Enable Checkpoint Inhibitor Efficacy. The project started on 01/12/2023 and ended on 28/02/2026.
